Social Cognition Intervention
ASCI
Augmenting Social Cognitive Intervention for Veterans With Schizophrenia
1 other identifier
interventional
153
1 country
1
Brief Summary
Veterans with schizophrenia and schizoaffective disorder experience high levels of disability and poor community outcome, and these poor functional outcomes constitute a major public health concern. The treatment of schizophrenia spectrum disorders has shifted fundamentally from a focus on symptom reduction to a focus on recovery and improving aspects of functioning. Needed improvements in community outcome for patients with these disorders will not occur simply through better control of clinical symptoms. Instead, it is necessary to find new treatments that address the key determinants of poor functional outcome, including social cognition. Both basic (non-social) cognition and social cognition are considered key determinants of functional outcome for schizophrenia and schizoaffective disorder. Basic cognition includes the domains of: learning and memory, vigilance / attention, speed of processing, reasoning and problem solving, and working memory. Social cognition generally refers to mental operations that underlie social interactions, including perceiving, interpreting, managing, and generating responses to socially relevant stimuli, including the intentions and behaviors of others. As part of the investigators' previous Merit grant, they have developed a training program for social cognition and are in the process of validating it. Initial results suggest that the program improves performance on measures of social cognition and functional capacity. In this study, the investigators will evaluate whether adding an in vivo component (training activities that occur in the community) to the current social cognition intervention facilitates generalization of training effects to community outcome and subjective satisfaction. Outcome measures of social cognition and functional capacity will be examined during the 12 week training program, and durability of benefits will be assessed at a 3-month follow up. Generalization to community functioning and subjective satisfaction will be assessed at the end of training and at the 3-month follow up. The investigators will enroll 105 patients across the 5 years of the study with random assignment to training group (social cognition intervention with in vivo exercises, social cognition intervention without in vivo exercises and control). Subjects will receive assessments at baseline, 6 weeks (mid-point), completion of training (12 weeks), and the 3-month follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2010
CompletedFirst Posted
Study publicly available on registry
December 24, 2010
CompletedStudy Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
March 15, 2017
CompletedMarch 15, 2017
January 1, 2017
4.8 years
December 23, 2010
November 15, 2016
January 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)
A standardized measure of emotion processing. It is scored as a standard score with a population mean of 100 and standard deviation of 15. It can range from 0 to 200. Higher is better. Note: Two of the study arms (in vivo and social cognitive training) receive identical procedures and produce identical outcome numbers for the first 6 weeks of the study.
baseline, 6 weeks, 12 weeks, and 3 months.
Secondary Outcomes (2)
The Awareness of Social Inference Test (TASIT)
baseline, 6 weeks, 12 weeks, and 3 months.
Profile of Nonverbal Sensitivity (PONS)
baseline, 6 weeks, 12 weeks, and 3 months.
Study Arms (3)
Arm 1: vivo augmentation
EXPERIMENTALsocial cognitive training with in vivo augmentation
Arm 2: social cognitive
ACTIVE COMPARATORsocial cognitive training
Arm 3: non-social skills
ACTIVE COMPARATORnon-social skills training
Interventions
24 sessions of social cognitive training plus 6 sessions of in vivo exercises
30 sessions of social cognitive training without in vivo exercises
30 sessions of skills training that has no specific social content
Eligibility Criteria
You may qualify if:
- All patients must be diagnosed with Schizophrenia, Schizoaffective Disorder, or Psychosis not otherwise specified (NOS) according to Diagnosis and Statistical Manual (DSM-IV) criteria. In addition, the subjects will meet the following criteria:
- Between 18 and 60 years of age
- Estimated premorbid intelligence quota \> 70 (based on reading ability)
- Understand spoken English sufficiently to comprehend testing procedures
- Clinically stable (e.g., no inpatient hospitalization in the 8 weeks prior to enrollment, no significant changes in medication in the 4 weeks prior to enrollment, and none anticipated for the 3 months of participation)
- In sufficient health to be able to walk outdoors unaided for at least 15 minutes.
You may not qualify if:
- No clinically significant neurological disease as determined by medical history
- No history of serious head injury (e.g., loss of consciousness longer than 1 hour)
- No physical, cognitive, or language impairment of such severity as to adversely affect the validity of data
- No evidence of drug or alcohol dependence in the past six months, and not intoxicated at time of testing based on urine toxicology screen and saliva alcohol test strip. Subjects who test positive will not be disqualified but instead will be asked to return for testing on a different day. However, subjects who test positive on 3 consecutive occasions will be disqualified from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073, United States
Related Publications (1)
Horan WP, Dolinsky M, Lee J, Kern RS, Hellemann G, Sugar CA, Glynn SM, Green MF. Social Cognitive Skills Training for Psychosis With Community-Based Training Exercises: A Randomized Controlled Trial. Schizophr Bull. 2018 Oct 17;44(6):1254-1266. doi: 10.1093/schbul/sbx167.
PMID: 29300973DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael F. Green, PhD
- Organization
- VA Greater Los Angeles, VISN 22 MIRECC
Study Officials
- PRINCIPAL INVESTIGATOR
Michael F Green, PhD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2010
First Posted
December 24, 2010
Study Start
February 1, 2011
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 15, 2017
Results First Posted
March 15, 2017
Record last verified: 2017-01